Literature DB >> 15564480

Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.

Pornwaratt Niyomrattanakit1, Pakorn Winoyanuwattikun, Santad Chanprapaph, Chanan Angsuthanasombat, Sakol Panyim, Gerd Katzenmeier.   

Abstract

Proteolytic processing of the dengue virus polyprotein is mediated by host cell proteases and the virus-encoded NS2B-NS3 two-component protease. The NS3 protease represents an attractive target for the development of antiviral inhibitors. The three-dimensional structure of the NS3 protease domain has been determined, but the structural determinants necessary for activation of the enzyme by the NS2B cofactor have been characterized only to a limited extent. To test a possible functional role of the recently proposed Phix(3)Phi motif in NS3 protease activation, we targeted six residues within the NS2B cofactor by site-specific mutagenesis. Residues Trp62, Ser71, Leu75, Ile77, Thr78, and Ile79 in NS2B were replaced with alanine, and in addition, an L75A/I79A double mutant was generated. The effects of these mutations on the activity of the NS2B(H)-NS3pro protease were analyzed in vitro by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of autoproteolytic cleavage at the NS2B/NS3 site and by assay of the enzyme with the fluorogenic peptide substrate GRR-AMC. Compared to the wild type, the L75A, I77A, and I79A mutants demonstrated inefficient autoproteolysis, whereas in the W62A and the L75A/I79A mutants self-cleavage appeared to be almost completely abolished. With exception of the S71A mutant, which had a k(cat)/K(m) value for the GRR-AMC peptide similar to that of the wild type, all other mutants exhibited drastically reduced k(cat) values. These results indicate a pivotal function of conserved residues Trp62, Leu75, and Ile79 in the NS2B cofactor in the structural activation of the dengue virus NS3 serine protease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564480      PMCID: PMC533897          DOI: 10.1128/JVI.78.24.13708-13716.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century.

Authors:  Duane J Gubler
Journal:  Trends Microbiol       Date:  2002-02       Impact factor: 17.079

Review 2.  Inhibiting viral proteases: challenges and opportunities.

Authors:  Elisabetta Bianchi; Antonello Pessi
Journal:  Biopolymers       Date:  2002       Impact factor: 2.505

3.  In vitro determination of dengue virus type 2 NS2B-NS3 protease activity with fluorescent peptide substrates.

Authors:  Rabuesak Khumthong; Chanan Angsuthanasombat; Sakol Panyim; Gerd Katzenmeier
Journal:  J Biochem Mol Biol       Date:  2002-03-31

4.  Yellow fever virus NS2B-NS3 protease: charged-to-alanine mutagenesis and deletion analysis define regions important for protease complex formation and function.

Authors:  D A Droll; H M Krishna Murthy; T J Chambers
Journal:  Virology       Date:  2000-09-30       Impact factor: 3.616

5.  Mutagenesis of the dengue virus type 2 NS3 proteinase and the production of growth-restricted virus.

Authors:  Anita E Matusan; Peter G Kelley; Melinda J Pryor; James C Whisstock; Andrew D Davidson; Peter J Wright
Journal:  J Gen Virol       Date:  2001-07       Impact factor: 3.891

6.  Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex.

Authors:  M A McCoy; M M Senior; J J Gesell; L Ramanathan; D F Wyss
Journal:  J Mol Biol       Date:  2001-02-02       Impact factor: 5.469

7.  Steady-state cleavage kinetics for dengue virus type 2 ns2b-ns3(pro) serine protease with synthetic peptides.

Authors:  Rabuesak Khumthong; Pornwarat Niyomrattanakit; Santad Chanprapaph; Chanan Angsuthanasombat; Sakol Panyim; Gerd Katzenmeier
Journal:  Protein Pept Lett       Date:  2003-02       Impact factor: 1.890

8.  Prime site binding inhibitors of a serine protease: NS3/4A of hepatitis C virus.

Authors:  Paolo Ingallinella; Daniela Fattori; Sergio Altamura; Christian Steinkühler; Uwe Koch; Daniel Cicero; Renzo Bazzo; Riccardo Cortese; Elisabetta Bianchi; Antonello Pessi
Journal:  Biochemistry       Date:  2002-04-30       Impact factor: 3.162

9.  Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors.

Authors:  D Leung; K Schroder; H White; N X Fang; M J Stoermer; G Abbenante; J L Martin; P R Young; D P Fairlie
Journal:  J Biol Chem       Date:  2001-10-01       Impact factor: 5.157

Review 10.  Pathogenesis of dengue: challenges to molecular biology.

Authors:  S B Halstead
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

View more
  39 in total

1.  Structural and functional parameters of the flaviviral protease: a promising antiviral drug target.

Authors:  Sergey A Shiryaev; Alex Y Strongin
Journal:  Future Virol       Date:  2010-09-01       Impact factor: 1.831

2.  Switching the substrate specificity of the two-component NS2B-NS3 flavivirus proteinase by structure-based mutagenesis.

Authors:  Sergey A Shiryaev; Boris I Ratnikov; Alexander E Aleshin; Igor A Kozlov; Nicholas A Nelson; Michal Lebl; Jeffrey W Smith; Robert C Liddington; Alex Y Strongin
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

3.  Conformational flexibility of DENV NS2B/NS3pro: from the inhibitor effect to the serotype influence.

Authors:  Erika Piccirillo; Benjamin Merget; Christoph A Sotriffer; Antonia T do Amaral
Journal:  J Comput Aided Mol Des       Date:  2016-02-29       Impact factor: 3.686

4.  Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[d]isothiazol-3(2H)-one derivatives.

Authors:  Kok-Chuan Tiew; Dengfeng Dou; Tadahisa Teramoto; Huiguo Lai; Kevin R Alliston; Gerald H Lushington; R Padmanabhan; William C Groutas
Journal:  Bioorg Med Chem       Date:  2011-12-30       Impact factor: 3.641

5.  Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses.

Authors:  Sergey A Shiryaev; Igor A Kozlov; Boris I Ratnikov; Jeffrey W Smith; Michal Lebl; Alex Y Strongin
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

6.  Ligand-bound structures of the dengue virus protease reveal the active conformation.

Authors:  Christian G Noble; Cheah Chen Seh; Alexander T Chao; Pei Yong Shi
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

7.  Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold.

Authors:  Alexander E Aleshin; Sergey A Shiryaev; Alex Y Strongin; Robert C Liddington
Journal:  Protein Sci       Date:  2007-03-30       Impact factor: 6.725

8.  Activation of the West Nile virus NS3 protease: molecular dynamics evidence for a conformational selection mechanism.

Authors:  Dariusz Ekonomiuk; Amedeo Caflisch
Journal:  Protein Sci       Date:  2009-05       Impact factor: 6.725

9.  Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains.

Authors:  Nikos Vasilakis; Eric B Fokam; Christopher T Hanson; Ethan Weinberg; Amadou A Sall; Stephen S Whitehead; Kathryn A Hanley; Scott C Weaver
Journal:  Virology       Date:  2008-08-01       Impact factor: 3.616

10.  Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides.

Authors:  Pornwaratt Niyomrattanakit; Sviatlana Yahorava; Ilze Mutule; Felikss Mutulis; Ramona Petrovska; Peteris Prusis; Gerd Katzenmeier; Jarl E S Wikberg
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.